David L. Rimm

机构：Yale Cancer Center, Yale University · ORCID：0000-0001-5820-4397

发表论文 1519 篇 · 总被引 72403 次 · h-index 135

代表论文

• Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer (2026 · npj Precision Oncology · 被引 2)
• Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC) (2026 · Nature Communications · 被引 2)
• Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score (2026 · Applied immunohistochemistry & molecular morphology · 被引 1)
• Prospective assessment of a quantitative immunofluorescent assay to measure HER2 and TROP2 concentrations on a single tissue biopsy slide (2026 · npj Breast Cancer)
• Quantification of Antibody–Drug Conjugate Targets in Head and Neck Squamous Cell Carcinoma (2026 · Molecular Cancer Therapeutics)
• Temperature-Dependent Long-term and Short-term Stability of Human Epidermal Growth Factor Receptor 2 Antigenicity on Pathology Slides (2026 · Archives of Pathology & Laboratory Medicine)